Skip to content

Atazanavir/ritonavir more likely to cause kidney stones than other ritonavir-boosted protease inhibitors

Male circumcision may not make much difference to overall male HIV incidence in Caribbean context

Attachment inhibitor BMS-663068 does well in early study involving HIV-positive people

"Treatment partners" improve short-term virologic outcomes in those starting HIV therapy

Low levels of innate immune activation and high levels of gut antibodies may protect people from HIV

Glucose metabolism worsens in HIV treatment-experienced taking NRTI-sparing regimens

Starting HIV treatment reduces risk of kidney disease

Patients with pain have poorer engagement with HIV care

New US guidelines recommend hepatitis C test for everyone born between 1945 and 1965